Pediatrix Medical Group, Inc. (NYSE:MD) Stock Now Rated “Hold” by Sell-Side Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have earned a consensus rating of “Hold” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $26.60.

A number of analysts have commented on MD shares. UBS Group raised their price objective on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Wall Street Zen raised shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 13th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $25.00 price objective on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. Weiss Ratings upgraded Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, September 9th. Finally, Truist Financial raised their price objective on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th.

Institutional Investors Weigh In On Pediatrix Medical Group

Several institutional investors have recently added to or reduced their stakes in the stock. Global Retirement Partners LLC acquired a new stake in Pediatrix Medical Group in the 2nd quarter valued at $33,000. Nykredit A S acquired a new stake in shares of Pediatrix Medical Group during the 2nd quarter worth $35,000. Signaturefd LLC lifted its stake in Pediatrix Medical Group by 301.8% during the third quarter. Signaturefd LLC now owns 2,013 shares of the company’s stock worth $52,000 after purchasing an additional 1,512 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in Pediatrix Medical Group during the 2nd quarter worth approximately $53,000. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Pediatrix Medical Group by 77.7% during the first quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company’s stock worth $54,000 after purchasing an additional 1,100 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Stock Down 1.1%

Shares of NYSE:MD opened at $28.98 on Tuesday. The firm has a 50 day simple moving average of $26.70 and a 200 day simple moving average of $23.72. The company has a market cap of $2.35 billion, a PE ratio of 13.87 and a beta of 0.61. Pediatrix Medical Group has a 52 week low of $16.90 and a 52 week high of $30.05. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.32.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. The firm had revenue of $487.78 million for the quarter, compared to the consensus estimate of $478.49 million. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The firm’s revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.53 earnings per share. As a group, research analysts expect that Pediatrix Medical Group will post 2.17 earnings per share for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc provides specialized physician-led healthcare services for women, infants and children. The company’s clinical offerings include neonatal and perinatal care, maternal-fetal medicine, pediatric medical subspecialties, pediatric hospitalist services and related services delivered in partnership with hospitals and healthcare systems.

Pediatrix-affiliated physicians and advanced practice providers generally work in hospital-based settings, including neonatal intensive care units, delivery rooms, pediatric units and outpatient practices.